Combined tumor-directed recruitment and protection from immune suppression enable CAR T cell efficacy in solid tumors

T cell recruitment to the tumor site. This sustained and improved infiltration of engineered T cells synergized with TGF-β shielding for improved therapeutic efficacy. Our results demonstrate that addition of CCR8 and DNR into CAR T cells can render them effective in solid tumors.

Combined tumor-directed recruitment and protection from immune suppression enable CAR T cell efficacy in solid tumors | Litlas